Physician

Andrew Richard Beardsley, M.D.

According to 2025 Medicare claims, Andrew Beardsley, M.D. (NPI: 1881855948) practices internal medicine in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 28806-2316. Beardsley is affiliated with the Mission Health Partners, LLC (ACO ID: A2591) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Beardsley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 933 traditional Medicare patients, billed 146,247 HCPCS/CPT codes, and received $3,581,424 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,933 prescription claims across 301 beneficiaries totaling $4,546,422 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 56 claims. Open Payments data shows 29 records totaling $247,104. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $14,082 to $3,581,424. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,868 to $4,546,422. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2018 Medicare payment: $14,082 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $47,314 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,952,698 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,568,796 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,720,873 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,121,643 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,581,424 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201885164$14,082
2019278690$47,314
202058293,830$1,952,698
2021666107,864$2,568,796
2022794127,323$2,720,873
202379588,105$2,121,643
2024933146,247$3,581,424

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.3M$4.5M2018 Drug cost: $3,868 (USD; Tot_Drug_Cst)2019 Drug cost: $1,028,889 (USD; Tot_Drug_Cst)2020 Drug cost: $1,119,809 (USD; Tot_Drug_Cst)2021 Drug cost: $1,493,228 (USD; Tot_Drug_Cst)2022 Drug cost: $1,916,546 (USD; Tot_Drug_Cst)2023 Drug cost: $1,962,993 (USD; Tot_Drug_Cst)2024 Drug cost: $4,546,422 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182046$3,868
2019131482$1,028,889
2020141651$1,119,809
2021171937$1,493,228
20221841,058$1,916,546
20231901,084$1,962,993
20243011,933$4,546,422

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.4K$2.8K2019 Medicare payment: $46 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,572 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,796 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R13$46
2020N/RN/RN/R
2021N/R11$1,572
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R56$2,796

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less161452$91
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more374761$89
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's319556$12
36415Insertion of needle into vein for collection of blood sample5761,278$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count5861,321$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TagrissoOsimertinib Mesylate321,200$673,466
RevlimidLenalidomide35903$551,282
PomalystPomalidomide22616$467,792
ImbruvicaIbrutinib381,064$457,712
AlecensaAlectinib Hcl23690$391,464

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R26$2,241
E0431Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R30$555

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$514Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.4$246,590Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew Richard Beardsley, M.D.?

Tedicare shows public-source Medicare data for Andrew Richard Beardsley, M.D. (NPI 1881855948), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Richard Beardsley, M.D. have ACO affiliation data?

Andrew Richard Beardsley, M.D. is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Andrew Richard Beardsley, M.D.?

Andrew Richard Beardsley, M.D. is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Andrew Richard Beardsley, M.D. have Open Payments data?

Andrew Richard Beardsley, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.